The FDA has issued a voluntary recall of Chantix, a smoking cessation drug, after finding “elevated levels of nitrosamines” in certain batches. These compounds, if consumed in high amounts over time, “may increase the risk of cancer.”

Health officials note that the exact danger from the detected levels is still uncertain, but nitrosamines are classified as possible carcinogens worldwide. The FDA says the recall is a precaution “to ensure patient safety and maintain rigorous standards.”

Patients are advised not to stop Chantix suddenly, as this could trigger withdrawal and disrupt progress. “Consult a healthcare provider” before making any changes, since doctors can suggest safer alternatives and help with the transition. Continues…